ArticleNucleic acid therapeutics2020

Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy.

Melina Christou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.